Trial: 201709159

A Phase III Study of AL3818 (Catequentinib,Anlotinib) Hydrochloride Monotherapy in Subjects with Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma

Phase

III

Principal Investigator

Van Tine, Brian

Disease Site

Soft Tissue

Learn more about this study at: clinicaltrials.gov